Categories: News

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024

WARSAW, Ind., Dec. 18, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024.

About Zimmer Biomet 

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. 

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2024-302334477.html

SOURCE Zimmer Biomet Holdings, Inc.

Staff

Recent Posts

Truemed and ThrivePass Partner to Expand Access to Healthcare Through HSA/FSA Dollars

New partnership empowers employees to use pre-tax dollars for functional medicine and health interventions, while…

2 hours ago

Smart Alert Tech Announces Breakthrough Patented Technology: The World’s First “Non-Event” Notifications

ORLANDO, Fla., Jan. 13, 2026 /PRNewswire/ -- Smart Alert Tech today announces a groundbreaking advancement…

2 hours ago

Medical Solutions CEO Rebecca Rogers Tijerino named to SIA’s Staffing 100 North America list

OMAHA, Neb., Jan. 13, 2026 /PRNewswire/ -- Medical Solutions, one of the nation's leading healthcare…

2 hours ago

Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease

SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Manifold Health AI today announced its launch at JPM…

2 hours ago

INTURAI VENTURES PROVIDES CORPORATE UPDATE

(CSE: URAI / OTC: URAIF / FSE: 3QG)                                                                                                    investor@inturai.comHighlightsU.S. OTC trading code has changed to URAIF, reflecting…

2 hours ago

Marvin Health Debuts AI Coaches for Clinicians at J.P. Morgan Healthcare Conference

Marvin's role-specific AI coaches will augment its 24/7 therapist network for its 100+ healthcare partners…

2 hours ago